In This Article:
NEW YORK, NY / ACCESSWIRE / June 11, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided.
Momo Inc. (MOMO)
Class Period: April 21, 2014 - April 29, 2019
Lead Plaintiff Deadline : July 15, 2019
Join the action: https://www.zlk.com/pslra-1/momo-inc-loss-form?prid=1908&wire=1
About the lawsuit: Momo Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (i) Momo's compliance procedures and controls were inadequate to prevent, inter alia, illicit financial reporting activity; (ii) Momo's social and dating app, Tantan, was materially noncompliant with PRC law and/or regulations; (iii) Tantan was consequently at an increased risk of being removed from Chinese app stores at the direction of Chinese governmental authorities; and (iv) as a result, Momo's public statements were materially false and misleading at all relevant times.
To learn more about the Momo Inc. class action contact jlevi@levikorsinsky.com.
Intersect ENT, Inc. (XENT)
Class Period: August 1, 2018 - May 6, 2019
Lead Plaintiff Deadline : July 15, 2019
Join the action: https://www.zlk.com/pslra-1/intersect-ent-inc-loss-form?prid=1908&wire=1
About the lawsuit: Throughout the class period, Intersect ENT, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Intersect lacked adequate reimbursement representatives to ensure physicians had access to SINUVA, Intersect's sinus implant; (2) Intersect's sales force would focus on ensuring reimbursement; (3) Intersect's sales representatives were less focused on driving sales; (4) physicians were less likely to adopt Intersect's SINUVA due to transaction costs associated with seeking reimbursement; (5) Intersect would increase staffing to address these issues; and (6) as a result of the foregoing, defendants' positive statements about Intersect's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more about the Intersect ENT, Inc. class action contact jlevi@levikorsinsky.com.
Box, Inc. (BOX)
Class Period: November 28, 2018 - June 3, 2019
Lead Plaintiff Deadline : August 6, 2019
Join the action: https://www.zlk.com/pslra-1/box-inc-loss-form?prid=1908&wire=1
About the lawsuit: During the class period, Box, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was unable to close large deals within the quarter; (2) that, as a result, the Company's revenue would be materially impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.